InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Pontifax Management 4 G.P. (2015) Ltd.. Officer active across 2 companies, notably Eloxx Pharmaceuticals, Inc.. In total, 3 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €2.9m. Activity tracked since 13 May 2021. The latest transaction was disclosed on 29 November 2022 (X). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
3,539 shares@ US$0.0001100.0% of flowCommon StockSEC:0001209191-22-059053:0
1,280,624 shares@ US$1.3550.0% of flowCommon StockSEC:0001104659-21-067336:0
Ideal exit: 7 Feb 2022 (T+270)
1,280,624 shares@ US$1.3550.0% of flowCommon StockSEC:0001104659-21-067336
Ideal exit: 7 Feb 2022 (T+270)
3 of 3 declarations
